Cargando…

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients

OBJECTIVE: To investigate the prevalence and prognosis of portopulmonary hypertension (PoPH) in liver transplant recipients. METHODS: Patients with advanced liver disease who underwent orthotopic liver transplantation (OLT) were included in this retrospective study from January 2012 to June 2015. Ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian, Zhuang, Qi, Zhang, Xueming, Zheng, Ying, Qiao, Zhiqing, Zhang, Jianjun, Shen, Xuedong, Shen, Jieyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167565/ https://www.ncbi.nlm.nih.gov/pubmed/30319722 http://dx.doi.org/10.1155/2018/9629570

Ejemplares similares

Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan
por: Tokushige, Katsutoshi, et al.
Publicado: (2023)

The early outcomes of candidates with portopulmonary hypertension after liver transplantation
por: Huang, Bingsong, et al.
Publicado: (2018)

Portopulmonary hypertension
por: Saleemi, Sarfraz
Publicado: (2010)

Venous outflow obstruction and portopulmonary hypertension after orthotopic liver transplantation
por: Aguirre-Avalos, Guadalupe, et al.
Publicado: (2013)

Living donor liver transplantation in a patient with severe portopulmonary hypertension
por: Singh, Shweta A, et al.
Publicado: (2020)

Liver transplantation for severe portopulmonary hypertension: A case report and literature review
por: Chen, Xiao-Jie, et al.
Publicado: (2019)

Role of echocardiography in screening for portopulmonary hypertension in liver transplant candidates: a meta-analysis
por: Yin, Xin, et al.
Publicado: (2020)

The Balance between the Left and Right Ventricular Deformation Evaluated by Speckle Tracking Echocardiography Is a Great Predictor of the Major Adverse Cardiac Event in Patients with Pulmonary Hypertension
por: Zhang, Xueming, et al.
Publicado: (2022)

Portopulmonary Hypertension: An Updated Review
por: Jasso-Baltazar, Erick A., et al.
Publicado: (2023)

Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates
por: Hayashi, Ryoko, et al.
Publicado: (2022)

Portopulmonary Hypertension: From Bench to Bedside
por: Thomas, Christopher, et al.
Publicado: (2020)

Causes and Circumstances of Death in Portopulmonary Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021)

Prevalence and Associated Factors of Portopulmonary Hypertension in Patients with Portal Hypertension: A Case-Control Study
por: Shao, Yueming, et al.
Publicado: (2021)

Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors
por: CHEN, HUI-SONG, et al.
Publicado: (2013)

Portopulmonary hypertension: Success with combined medical treatment
por: Hernández, María, et al.
Publicado: (2023)

Prevalence and Clinical Features of Portopulmonary Hypertension in Patients With Hepatic Cirrhosis: An Echocardiographic Study
por: Gupta, Anany, et al.
Publicado: (2022)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension
por: Saleemi, Sarfraz, et al.
Publicado: (2014)

Apply pressure-strain loop to quantify myocardial work in pulmonary hypertension: A prospective cohort study
por: Wang, Jian, et al.
Publicado: (2022)

The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
por: Takahashi, Yukiko, et al.
Publicado: (2021)

Current clinical understanding and effectiveness of portopulmonary hypertension treatment
por: Tamura, Yuichi, et al.
Publicado: (2023)

Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg
por: DuBrock, Hilary M., et al.
Publicado: (2020)

Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes
por: del Valle, Kathryn T., et al.
Publicado: (2022)

Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease
por: Wakabayashi, Shun‐Ichi, et al.
Publicado: (2023)

Portopulmonary hypertension caused by portal hypertension that is complicated by central diabetes insipidus
por: Zhao, Tingting, et al.
Publicado: (2020)

Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease
por: Wakabayashi, Shun-ichi, et al.
Publicado: (2021)

Integrative analysis reveals key mRNA and long non-coding RNA interaction in idiopathic pulmonary arterial hypertension
por: Wang, Ruomeng, et al.
Publicado: (2020)

BMP9 Morphs into a Potential Player in Portopulmonary Hypertension
por: Toshner, Mark
Publicado: (2019)

Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes
por: DuBrock, Hilary M., et al.
Publicado: (2019)

Possible use of pulmonary artery stiffness in screening for portopulmonary hypertension
por: Wessels, Jeroen N., et al.
Publicado: (2022)

Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis
por: Krowka, Michael, et al.
Publicado: (2020)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

What do we take consideration in the patient who has an unpredicted severe portopulmonary hypertension in liver transplantation?: a case report
por: Koh, HyunJung, et al.
Publicado: (2015)

Left main coronary artery compression in a patient with portopulmonary hypertension
por: de Araújo, Iara Teixeira, et al.
Publicado: (2018)

Association between Body Composition and the Risk of Portopulmonary Hypertension Assessed by Computed Tomography in Patients with Liver Cirrhosis
por: Miwa, Takao, et al.
Publicado: (2023)

Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review
por: Li, Niuniu, et al.
Publicado: (2023)

Sarcoidosis-induced pericarditis in a patient with portopulmonary hypertension: a case report
por: Giouleme, Olga, et al.
Publicado: (2009)

Natural killer cell-mediated immune deficiency or compromise in patients with portopulmonary hypertension
por: Chen, Huisong, et al.
Publicado: (2014)

Portopulmonary hypertension in children: a rare but potentially lethal and under-recognized disease
por: Tingo, Jennifer, et al.
Publicado: (2017)

Management of acute subdural hematoma in a patient with portopulmonary hypertension on prostanoid therapy
por: Rammo, Richard, et al.
Publicado: (2017)

Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis
por: Türker, Fatih, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5u4d3im5buj3rovpfg3ve0njn